Conyza bonariensis (Zèb-Kodenn) : propiedades medicinales en extracción alcohólica

Conyza bonariensis (Zèb-Kodenn, hierba de gallo de la India, herbe-à-coq d’Inde, Indian cock’s-foot) — familia Asteracées.

Sinónimos científicos : Erigeron bonariensis-L, Leptilon bonariense-(L)-Small..

Esta base documenta las extracciones alcohólicas (etanol) de las sustancias activas. Nuestra monografía recoge actualmente 6 indicaciones en extracción alcohólica para esta especie. El catálogo Lapo v2 registra 35 referencias científicas para esta especie (detalle completo en la aplicación).

Indicaciones terapéuticas en extracción alcohólica:

Importante — referencias científicas en esta página pública: solo se muestra un breve extracto de cada fuente citada (frases de resumen seleccionadas), conservado en el idioma original de la publicación (casi siempre el inglés), sin traducir. Estos extractos no constituyen el texto íntegro del artículo ni una bibliografía completa. Las fichas de referencia completas y el detalle monográfico están disponibles en la aplicación Lapo v2 (prueba gratuita de 30 días).

1. 1

   Diabetes mellitus tipo II

   Parte usada: Hoja.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon Akhtar MF (2021)

     Extrait The plant extract (250 & 500mg/kg/day) was explored for its anti-hyperglycemic effect for 14 days in normoglycemic & alloxan-induced diabetic rats using the oral glucose tolerance test (OGTT). To evaluate the anti-diabetic potential of aqueous methanolic extract of Conyza bonariensis amongst the Wistar rats.

   • Selon MUSTAFA I (2024)

     Extrait Total oxidant status (TOS) and the serum glucose levels of the streptozotocin-treated rats were reduced significantly (P ⩽ .05) in Conyza bonariensis treated group. This study was conducted to assess the possible antidiabetic potential of Conyza bonariensis by employing in vitro as well as in vivo assessments.

   • Selon Saleem M (2021)

     Extrait The plant extract (250 a&500mg/kg/day) was explored for its anti-hyperglycemic effect for 14 days in normoglycemic & alloxan-induced diabetic rats using the oral glucose tolerance test (OGTT). To evaluate the anti-diabetic potential of aqueous methanolic extract of Conyza bonariensis amongst the Wistar rats.

   • Selon AL-KAZMAN BSM (2025)

     Extrait Conyza bonariensis (CB), a traditional medicinal plant, has demonstrated antioxidant, anti-inflammatory, and hepatoprotective properties, making it a promising candidate for NAFLD therapy. Non-alcoholic fatty liver disease (NAFLD) is a rising global health concern closely linked with obesity, insulin resistance, and metabolic syndrome.

2. 2

   Cáncer: tratamiento adyuvante del carcinoma hepático y de mama

   Parte usada: Hoja.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon Saleem M (2014)

     Extrait The hepatoprotective activity of Conyza bonariensis ethanol extract was studied against paracetamol induced hepatotoxicity in mice. The results showed that an extract of C.B (250 mg/kg & 500 mg/kg) produced (p<0.05) decline in paracetamol induced liver marker enzymes & total bilirubin, but its 750 mg/kg showed remarkable decline in ALT, AST, ALP & TB levels, compared to the reference levels of silymarin & results were supported by histopathology of liver section.

   • Selon AL-KAZMAN BSM (2025)

     Extrait In vivo, extract-treated groups showed significant improvement in liver function tests, lipid profiles, and oxidative stress markers (p < 0.05), with the highest dose group (750 mg/kg) displaying histologically reduced hepatic steatosis and inflammation. Conyza bonariensis (CB), a traditional medicinal plant, has demonstrated antioxidant, anti-inflammatory, and hepatoprotective properties, making it a promising candidate for NAFLD therapy.

   • Selon BATOOL S (2025)

     Extrait The leaf extract, showing the most promising anticancer activity, was further analyzed against liver cancer cells, yielding an IC50 value of 1.72 μg mL−1. These compounds, primarily the leaf extract, demonstrated notable activity against liver & breast cancer.

   • Selon LAHNGONG M (2025)

     Extrait Conyza bonariensis (L.) Cronquist) is a medicinal plant with traditional use in Cameroonian folk medicine & other parts of Africa for the management of ailments, including malaria. Additionally, cytotoxicity was assessed on the MDA-MB-231 breast cancer cell line, while acute & sub-chronic toxicity were evaluated using albino mice.

   • Selon Akhtar MF (2021)

     Extrait To evaluate the anti-diabetic potential of aqueous methanolic extract of Conyza bonariensis amongst the Wistar rats. The plant extract revamped the pancreatic islets of Langerhans & abridged alloxan-induced degenerative changes in the liver.

3. 3

   Infección fúngica: Candida albicans, C. parapsilosis, Malassezia furfur, M. globosa, M. sympodialis, Microsporum canis, Trichophyton rubrum, T. mentagrophytes

   Parte usada: Hoja.

   Références scientifiques (courts extraits)

   Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.

   • Selon Mussin je (2017)

     Extrait parapsilosis), 17 dermatophytes (6 Trichophyton rubrum, 6 Trichophyton mentagrophytes, 5 Microsporum canis) & 6 Staphylococcus aureus. Conclusions: Results allow to conclude that the CB tincture displays antibacterial activity against Staphylococcus aureus & antifungal activity against the main fungi causing superficial infections, such as dermatophytes, Candida & Malassezia.

   • Selon GIRMA Y (2021)

     Extrait Antimicrobial activity of the extracts was evaluated against pathogenic fungi causing superficial infection (Candida albicans, Malassezia globosa, & Malassezia furfur). In this study, crude extracts from leaves of Conyza bonariensis were prepared using methanol, ethyl acetate, hexane, & chloroform.

   • Selon ARAUJO L (2013)

     Extrait Additionally, the essential oil presented a significant bactericidal effect against Bacillus cereus, while a moderate activity was observed against Staphylococcus epidermidis & Candida albicans. The essential oil from aerial parts of Conyza bonariensis (L) Cronquist collected in Mérida was obtained by hydrodistillation & analysed by GC/MS.

   • Selon MPENDA FN (2024)

     Extrait Methods: Initial experimental activities involved preparation of crude extracts & EO, which were then, tested for antimicrobial activity against selected test organisms (Staphylococcus aureus (ATCC29213), Bacillus subtilis (ATCC6051), Escherichia coli (ATCC8736), Salmonella typhi (ATCC6539), & Candida albicans (DSM1665)) by using the disc diffusion method. albicans, where the MIC was 50 mg/mL > MIC > 25 mg/mL.

   • Selon NSINDAGI SP (2023)

     Extrait Then crude extracts were tested against selected microorganisms: Two Gram-positive bacteria, Staphylococcus aureus & Bacillus subtilis; Two Gram-negative bacteria, Escherichia coli & Salmonella typhi, & a yeast Candida albicans.

Otras indicaciones (incluidos otros modos de extracción si procede), posologías, precauciones de uso y las <strong>referencias científicas completas</strong> (fichas íntegras, no solo los extractos cortos anteriores) están disponibles en la ficha monográfica de la aplicación Lapo v2.